Focused Stereotactic Radiation Treatment of Prostatic Adenocarcinoma

NCT03284151 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 26

Last updated 2022-06-22

No results posted yet for this study

Summary

Focused stereotactic radiation treatment of localized prostatic adenocarcinoma. in order to quantify the delay between the focused treatment and the salvage procedure.

Conditions

Interventions

RADIATION

Cyberknife

Sponsors & Collaborators

  • Centre Francois Baclesse, Luxembourg

    lead OTHER

Principal Investigators

  • Philippe Nickers, MD, PhD · Centre Francois Baclesse

  • Michel Untereiner, MD · Centre Francois Baclesse

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2020-01-31
Completion
2023-01-31

Countries

  • Luxembourg

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03284151 on ClinicalTrials.gov